How compounding pharmacies can make GLP-1 weight loss drugs

The Super Bowl ad under fire from lawmakers On Friday, two lawmakers sent a letter to the FDA arguing that a Super Bowl ad from the telehealth company Hims & Hers could potentially be misleading people by omitting information on safety or side effects. The two senators — Democrat Dick Durbin of Illinois and Republican Roger Marshall of Kansas — also believe that the FDA could already have the authority to take enforcement action like warning letters or civil penalties. The commercial, which was released online ahead of its television slot during the game, condemns the weight loss industry for generating big profits without actually helping people. Yet the pharmaceutical industry the ad takes shots at is paradoxically held to higher marketing standards than Hims & Hers, which sells compounded versions of the blockbuster GLP-1s. Immediately after its release, observers told STAT’s Katie Palmer that they were “shocked” by the “irresponsible” ad. Read more on the latest from STAT’s Mario Aguilar. (And for a refresher on what the deal is with compounded weight loss drugs, watch our video explainer.) ‘Incredibly irresponsible’: Hims Super Bowl ad downplays risks of compounded drugs Telehealth provider’s splashy ad underplays risks of medications not approved by the FDA https://www.statnews.com/2025/01/28/super-bowl-ad-hims-and-hers-telehealth-company-downplays-risks-compounded-drugs/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz--Hm2Sukm4IphlZcefvEfBVAMH_XMyJ5rhB-xdCyhRoy11rvHToqWBmSa5sIjZ4sHcxkr5ztep3nlvvc23ofddmuXBDVw&_hsmi=346446342&utm_content=346446342&utm_source=hs_email